Healthcare Analysts discuss Short Bowel Syndrome (SBS) ahead Of upcoming Phase III Data for Ironwood Pharmaceuticals on an Analyst/Industry conference call to be held on February 12.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IRWD:
- Piper Sandler healthcare analysts to hold an analyst/industry conference call
- Craig-Hallum bullish on Ironwood, initiates with a Buy
- Ironwood initiated with a Buy at Craig-Hallum
- Ironwood price target raised to $10.50 from $9 at TD Cowen
- Ironwood announces publication of Phase III study in The Lancet